NVST
$26.05
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally.
Recent News
Best Value Stocks to Buy for March 16th
OPRX, NVST and STRT made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 16, 2026.
All You Need to Know About Envista (NVST) Rating Upgrade to Strong Buy
Envista (NVST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Value Stocks to Buy for March 12th
EAT, PAHC and NVST made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 12th, 2026.
Here's Why Envista (NVST) Is a Great 'Buy the Bottom' Stock Now
Envista (NVST) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Assessing Envista Holdings (NVST) Valuation After Recent Pullback And Rebound In Share Performance
What sparked fresh interest in Envista Holdings? With no single headline event grabbing attention, Envista Holdings (NVST) has drawn investor interest around its recent share performance and underlying dental business, prompting a closer look at how the stock currently stacks up. See our latest analysis for Envista Holdings. The recent 1 day share price return of 3.83% decline and 7 day return of 8.05% decline sit against a stronger 90 day share price return of 34.23% and 1 year total...